Fact CheckerSign in

NCT06124300Completed

Effects of a Female Hormone Balance Supplement on Symptoms of Polycystic Ovary Syndrome and Severe Premenstrual Syndrome

A Single Group Study to Evaluate the Effects of a Female Hormone Balance Supplement on Symptoms of Polycystic Ovary Syndrome and Severe Premenstrual Syndrome

Source: ClinicalTrials.gov · Last updated 23 Aug 2024

Brief summary (registry, in English)

This is a virtual single group study that will last 12 weeks. Participants will take 1 scoop of the female hormone balance supplement, and mix it with their drink of choice every morning. Questionnaires will be completed at baseline, 1 week, 2 weeks, 4 weeks, and 12 weeks

Status (registry)
Completed
Study type
Interventional
Enrollment
40 (actual)
First submitted
4 Nov 2023
Start date
30 Aug 2023
Primary completion date
19 Jan 2024
Lead sponsor
Rael
NCT number
NCT06124300

What you commit to

  • Study type: Interventional
  • Participants enrolled: 40
  • From 30 Aug 2023 to the primary completion date, 19 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
  • Anyone with known severe allergic reactions

Other

  • Anyone who is pregnant, breastfeeding, or attempting to become pregnant
  • Unwilling to follow the study protocol

Who the study is looking for

  • Women aged between 18 - 55
  • BMI less than 35
  • Self-reported concerns around irregular menstrual cycles and ovulation, mood swings, stress, irritability, and low energy
  • Generally healthy - don't live with any uncontrolled chronic disease
  • Self-reported symptoms of PCOS - irregular periods
  • Self-reported concerns with hormonal skin issues

Age in the registry: 18 years to 55 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Citruslabs
Coordinator of this site? Confirm its status
Santa MonicaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.